Results 201 to 210 of about 161,517 (244)
Evaluation of Crushed Posaconazole Delayed Release Tablets in Lung Transplant Recipients. [PDF]
Gordon R+7 more
europepmc +1 more source
1925-2025: a century of international pharmaceutical law. [PDF]
Riboulet-Zemouli K.
europepmc +1 more source
[Treatment of psoriatic arthritis with the delayed-action preparation kenalog-40].
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Bioverfügbarkeit von retardierten und nicht-retardierten Isosorbid-5-nitrat-Präparaten
DMW - Deutsche Medizinische Wochenschrift, 2008In a randomized crossover study on twelve healthy test subjects, the plasma concentration of isosorbide-5-nitrate (IS-5-N) after oral administration of 40 mg IS-5-N daily from two standard preparations (two tablets Ismo 20 or Corangin 20) and two sustained release preparations with 40 mg or 60 mg IS-5-N (one tablet Corangin 40 or Corangin 60) once a ...
R. Heidemann+3 more
openaire +3 more sources
[Bioavailability of a delayed-action aminophylline preparation].
Minerva medica, 1985Absorption of theophylline from one commercial product labelled as aminophylline sustained release was compared to the absorption from an oral solution of aminophylline in a single-dose bioavailability study. Aminomal-R tablets had bioavailability (101.2 +/- 19) statistically indistinguishable from that of the standard but showed significantly slower ...
M B, Regazzi+4 more
openaire +1 more source
[Clinical effectiveness of delayed-action theophylline preparations].
Klinicheskaia meditsina, 1991Clinical efficiency of course treatment has been assessed for 5 long-acting drugs of theophylline series: retaphylline (Finland), theo-dur (Sweden), durophylline (Yugoslavia), theopek and theobilong (USSR). The drugs were tested in 139 patients with chronic++ bronchial obstruction.
A N, Tsoĭ+4 more
openaire +1 more source
[Treatment of osteoporosis with a delayed-action sodium fluoride preparation].
Zeitschrift fur Rheumatologie, 197740 patients with various types of osteoporosis, aged 17 to 76 years, were treated for 12 months with a new NaF-drug (Ossiplex-Retard, film tbl. 25 mg NaF plus 200 mg vitamine C). Daily dosage was 50-100 mg. Clinical symptoms, X-ray-status of the axial skeleton, alkaline serum phosphatase and the consumption of analgetics were used for assessment.
openaire +1 more source
[Delayed-action preparations of phenobarbital].
Therapie, 1973A M, Nicaise, J, Pollet
openaire +1 more source